JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO

Adam, S; Simon, N; Steffen, U; Harre, N; Andes, F; Muller, D; Culemann, S; Andreev, D; Hahn, M; Scholtysek, C; Schett, G; Kronke, G; Frey, S; Hueber, A

ANNALS OF THE RHEUMATIC DISEASES, 2019; 78 (): 110

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索